Sage Journals: Discover world-class research

Open access

Case report

First published 2019

Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis–Related Diabetes

Francis Christian, Andrew Thierman, Erin Shirley [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2024-6

Evaluation of Teratogenic Profile of Combination of Lumacaftor and Ivacaftor in Sprague–Dawley Rats

Kattula Rao Vinay Rajan, K. Eswar Kumar

Journal of Pharmacology and Pharmacotherapeutics

Open access

Research article

First published 2024

Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden

Mahasin Al Shakirchi, Kimmo Sorjonen, Lena Hjelte [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2024

Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials

Rong He, Fei Lin, Zehui Deng [...]

Sage Open Medicine

Retricted access

Research article

First published 2019-3

Ivacaftor,a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator,Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

Do-Yeon Cho, Dong Jin Lim, Calvin Mackey [...]

American Journal of Rhinology & Allergy

Free access

Review article

First published 2015-12

Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects

Kelly Kuk, Jennifer L. Taylor-Cousar

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2013-10

Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence

Kavitha Kotha, John P. Clancy

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2019

Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor

Jaime L. Rubin, Lasair O’Callaghan, Christopher Pelligra [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2019

The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy

Sherstin T. Lommatzsch, Jennifer L. Taylor-Cousar

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2022

Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis

Lijia Zhang, Dana Albon, Marieke Jones [...]

Therapeutic Advances in Respiratory Disease

Search results